Literature DB >> 10086674

To B or not to B: is tylosis B truly benign? Two North American genealogies.

R H Maillefer1, M P Greydanus.   

Abstract

Tylosis is a rare, autosomal dominant syndrome presenting with hyperkeratosis of the palms and soles of the feet. Two types have been identified. Late onset tylosis (type A) is reported to be associated with a high incidence of esophageal carcinoma, whereas early onset tylosis (type B) appears to be a benign disorder. This distinction has significant implications for surveillance and prognosis. We report two families exhibiting early onset type B tylosis, spanning five and seven generations, respectively, and believe these to be the first two extensive genealogies of tylosis type B reported in North America. They serve to verify the features of type B tylosis and its benign prognosis. The world literature is reviewed and clinical relevance is discussed. Recommendations for follow-up of afflicted individuals are proposed.

Entities:  

Mesh:

Year:  1999        PMID: 10086674     DOI: 10.1111/j.1572-0241.1999.00954.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  4 in total

Review 1.  Esophageal manifestations of dermatologic disease.

Authors:  James L Wise; Joseph A Murray
Journal:  Curr Gastroenterol Rep       Date:  2002-06

2.  Palmoplantar keratoderma is associated with esophagus squamous cell cancer in Van region of Turkey: a case control study.

Authors:  Mahmut Ilhan; Tugrul Erbaydar; Necmettin Akdeniz; Sevket Arslan
Journal:  BMC Cancer       Date:  2005-07-28       Impact factor: 4.430

3.  Non-acid gastro-oesophageal reflux is associated with squamous cell carcinoma of the oesophagus.

Authors:  Mpho Kgomo; Taole R Mokoena; James A Ker
Journal:  BMJ Open Gastroenterol       Date:  2017-11-14

4.  Uncommon Endoscopic Findings in a Tylosis Patient: A Case Report.

Authors:  Balarama K Surapaneni; Pragnan Kancharla; R Vinayek; Sudhir K Dutta; Mendel Goldfinger
Journal:  Case Rep Oncol       Date:  2019-05-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.